These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24306005)

  • 1. The questionable use of unequal allocation in confirmatory trials.
    Hey SP; Kimmelman J
    Neurology; 2014 Jan; 82(1):77-9. PubMed ID: 24306005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the modified Zelen's approach randomization and dynamic randomization with partial block supplies at the centers to unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Contemp Clin Trials; 2011 Nov; 32(6):962-72. PubMed ID: 21888990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomization in clinical trials in orthodontics: its significance in research design and methods to achieve it.
    Pandis N; Polychronopoulou A; Eliades T
    Eur J Orthod; 2011 Dec; 33(6):684-90. PubMed ID: 21320892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of unequal randomisation ratios in clinical trials: a review.
    Dumville JC; Hahn S; Miles JN; Torgerson DJ
    Contemp Clin Trials; 2006 Feb; 27(1):1-12. PubMed ID: 16236557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
    Sverdlov O; Ryeznik Y
    Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal designs for two-arm, phase II clinical trial design with multiple constraints.
    Mayo MS; Mahnken JD; Soong SJ
    J Biopharm Stat; 2010 Jan; 20(1):106-24. PubMed ID: 20077252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-trial networking in AML: a step forward rather than corner cutting.
    Büchner T; Döhner H; Ehninger G; Ganser A; Niederwieser D; Hasford J
    Leuk Res; 2004 Jun; 28(6):649-50. PubMed ID: 15120943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harms of outcome switching in reports of randomised trials: CONSORT perspective.
    Altman DG; Moher D; Schulz KF
    BMJ; 2017 Feb; 356():j396. PubMed ID: 28196813
    [No Abstract]   [Full Text] [Related]  

  • 9. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2012 Apr; 31(8):701-23. PubMed ID: 22161821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical dynamic allocation procedures based on modified Zelen's approach in multiregional studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    J Biopharm Stat; 2014; 24(4):785-801. PubMed ID: 24697592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist.
    Porcino AJ; Shamseer L; Chan AW; Kravitz RL; Orkin A; Punja S; Ravaud P; Schmid CH; Vohra S;
    BMJ; 2020 Feb; 368():m122. PubMed ID: 32107202
    [No Abstract]   [Full Text] [Related]  

  • 12. The pursuit of balance: An overview of covariate-adaptive randomization techniques in clinical trials.
    Lin Y; Zhu M; Su Z
    Contemp Clin Trials; 2015 Nov; 45(Pt A):21-5. PubMed ID: 26244705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guessing strategies for treatment prediction under restricted randomization with unequal allocation.
    Zhao W; Everett CC; Weng Y; Berger VW
    Contemp Clin Trials; 2017 Aug; 59():118-120. PubMed ID: 28526265
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond randomization.
    Aickin M
    J Altern Complement Med; 2002 Dec; 8(6):765-72. PubMed ID: 12614529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of designing a clinical trial: part I.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Sep; 27(5):257-9. PubMed ID: 10999963
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomisation in clinical trials.
    Beller EM; Gebski V; Keech AC
    Med J Aust; 2002 Nov; 177(10):565-7. PubMed ID: 12429008
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding experimental arms to platform clinical trials: randomization procedures and interim analyses.
    Ventz S; Cellamare M; Parmigiani G; Trippa L
    Biostatistics; 2018 Apr; 19(2):199-215. PubMed ID: 29036330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies.
    Büchner T; Döhner H; Ehninger G; Ganser A; Hasford J;
    Leuk Res; 2002 Dec; 26(12):1073-5. PubMed ID: 12443878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials.
    Siegfried N; Clarke M; Volmink J; Van der Merwe L
    PLoS One; 2008; 3(10):e3491. PubMed ID: 18941523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.